Home > Insider Trading > Filing (0001179110-17-013545)

Filing Details

Accession Number:: 0001179110-17-013545
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-10-30 19:30:13
Reporting Period:: 2017-10-27

Accepted Time:: 2017-10-30 19:30:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1461466	Dayton Misfeldt	C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-27	392,520	$2.00	1,598,260	No	4	P	Indirect	See footnotes.
Common Stock	Acquisiton	2017-10-27	7,480	$2.00	30,456	No	4	P	Indirect	See footnotes.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes.
No	4	P	Indirect	See footnotes.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2017-10-27	196,260	$0.00	196,260	$3.00
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2017-10-27	3,740	$0.00	3,740	$3.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
196,260	2017-10-27	2018-10-27	No	4	P	Indirect
3,740	2017-10-27	2018-10-27	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	252	Indirect	See footnotes.

Footnotes

The reporting person is a Managing Director of Bay City Capital LLC, a Delaware limited liability company ("BCC"). BCC is the manager of Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"). Management V is the general partner of Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V") and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held. Mr. Misfeldt, BCC and Management V disclaim beneficial ownership with respect to the securities reported in this Form 4, except to the extent of their pecuniary interest therein.
The securities are held by Fund V.
The securities are held by Co-Investment V.
The securities are held by BCC.
The reported securities are included within the 392,520 shares of common stock and accompanying warrants purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock.
The reported securities are included within the 7,480 shares of common stock purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock.